139 related articles for article (PubMed ID: 38562367)
21. [Dermatofibrosarcoma protuberans: case report].
Kozarev J; Cuk D
Med Pregl; 1999; 52(1-2):71-3. PubMed ID: 10352509
[TBL] [Abstract][Full Text] [Related]
22. Autoamputation of Dermatofibrosarcoma Protuberans: A Novel and Rare Presentation of a Familiar Entity.
Jebastin Thangaiah J; Williamson SR; Pimentel J; Perry K
Int J Surg Pathol; 2019 Aug; 27(5):531-534. PubMed ID: 30813811
[TBL] [Abstract][Full Text] [Related]
23. Dermatofibrosarcoma protuberans in two patients with acquired immunodeficiency syndrome.
Sapadin AN; Gelfand JM; Howe KL; Phelps RG; Grand D; Rudikoff D
Cutis; 2000 Feb; 65(2):85-8. PubMed ID: 10696559
[TBL] [Abstract][Full Text] [Related]
24. Dermatofibrosarcoma Protuberans.
Reha J; Katz SC
Surg Clin North Am; 2016 Oct; 96(5):1031-46. PubMed ID: 27542641
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Challenges of Dermatofibrosarcoma Protuberans (DFSP), a Rare Spindle Cell Tumor of Breast.
Mohammed SY; Sadiq Q; Mcgregor D; Khan F
Cureus; 2021 Dec; 13(12):e20643. PubMed ID: 35106202
[TBL] [Abstract][Full Text] [Related]
26. Unforeseen clonal evolution of tumor cell population in recurrent and metastatic dermatofibrosarcoma protuberans.
Oh E; Jeong HM; Kwon MJ; Ha SY; Park HK; Song JY; Kim YJ; Choi JS; Lee EH; Lee J; Choi YL; Shin YK
PLoS One; 2017; 12(10):e0185826. PubMed ID: 28977029
[TBL] [Abstract][Full Text] [Related]
27. Dermatoscopic findings of atrophic dermatofibrosarcoma protuberans.
Akay BN; Unlu E; Erdem C; Heper AO
Dermatol Pract Concept; 2015 Jan; 5(1):71-3. PubMed ID: 25692086
[TBL] [Abstract][Full Text] [Related]
28. Atrophic Pigmented Dermatofibrosarcoma Protuberans: A Case Report and Literature Review.
Bai J; Liu B; Liu T; Qiao J; Fang H
Front Oncol; 2021; 11():669754. PubMed ID: 34221984
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic metastasis of dermatofibrosarcoma protuberans: a rare case.
Chilukuri DS; Premkumar P; Venkitaraman B; Soundararajan JCB
BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31980476
[TBL] [Abstract][Full Text] [Related]
30. Perspectives of Patients With Dermatofibrosarcoma Protuberans on Diagnostic Delays, Surgical Outcomes, and Nonprotuberance.
David MP; Funderburg A; Selig JP; Brown R; Caliskan PM; Cove L; Dicker G; Hoffman L; Horne T; Gardner JM
JAMA Netw Open; 2019 Aug; 2(8):e1910413. PubMed ID: 31469398
[TBL] [Abstract][Full Text] [Related]
31. Dermatofibrosarcoma protuberans in a pre-adolescent child.
Wickramasinghe VC; Saranga KGV; Piyarathne SA; Prashantha AHA; Liyanage AKG
Int J Surg Case Rep; 2023 Sep; 110():108761. PubMed ID: 37666158
[TBL] [Abstract][Full Text] [Related]
32. Case report: Identification of a novel heterozygous germline
Zhang Q; Ju Y; You X; Sun T; Ding Y
Front Oncol; 2022; 12():966020. PubMed ID: 36033485
[TBL] [Abstract][Full Text] [Related]
33. Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation.
Rutkowski P; Klimczak A; Ługowska I; Jagielska B; Wągrodzki M; Dębiec-Rychter M; Pieńkowska-Grela B; Świtaj T
Eur J Surg Oncol; 2017 Jun; 43(6):1134-1141. PubMed ID: 28365129
[TBL] [Abstract][Full Text] [Related]
34. Target therapy of unresectable or metastatic dermatofibrosarcoma protuberans with imatinib mesylate: an analysis on 22 Chinese patients.
Wang C; Luo Z; Chen J; Zheng B; Zhang R; Chen Y; Shi Y
Medicine (Baltimore); 2015 May; 94(17):e773. PubMed ID: 25929918
[TBL] [Abstract][Full Text] [Related]
35. Vulvar Dermatofibrosarcoma protuberance in Iran and a narrative review of literature: A first case report.
Arab M; Faghih N; Asghari M; Agha Majidi M; Ghavami B; Noori Ardebili S
Caspian J Intern Med; 2023; 14(3):572-576. PubMed ID: 37520865
[TBL] [Abstract][Full Text] [Related]
36. Clinical Features, Pathological Findings and Treatment of Recurrent Dermatofibrosarcoma Protuberans.
Li Y; Wang C; Xiang B; Chen S; Li L; Ji Y
J Cancer; 2017; 8(7):1319-1323. PubMed ID: 28607608
[TBL] [Abstract][Full Text] [Related]
37. [An uncommon malignancy of the breast: dermatofibrosarcoma protuberans with fibrosarcomatous transformation (DFSP-FS)].
Ledniczky G; Bognár G; Diczházi C; Bereczky B; Barabás L; Ondrejka P
Magy Seb; 2009 Feb; 62(1):27-9. PubMed ID: 19218166
[TBL] [Abstract][Full Text] [Related]
38. Atrophic dermatofibrosarcoma protuberans with diffuse eosinophilic infiltrate.
Hirashima N; Misago N; Shinogi T; Inoue T; Miura Y; Narisawa Y
J Dermatol; 2006 Jul; 33(7):486-8. PubMed ID: 16848822
[TBL] [Abstract][Full Text] [Related]
39. Role of ultrasound in the diagnosis of primary and recurrent dermatofibrosarcoma protuberans.
Zou MH; Huang Q; Yang T; Jiang Y; Zhang LJ; Xie Y; Zheng RQ
BMC Cancer; 2021 Aug; 21(1):909. PubMed ID: 34376150
[TBL] [Abstract][Full Text] [Related]
40. Dermatofibrosarcoma Protuberans in a Patient With Cowden Syndrome: Revisiting the PTEN and PDGF Pathways.
Smith EH; Lan TT; Jo VY; Fullen DR; Chan MP
Am J Dermatopathol; 2016 Apr; 38(4):e40-3. PubMed ID: 26488716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
